News & Events

Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy Endpoints

TCT 2023: A Deep Dive on ALIGN-AR

ALIGN-AR Trial Data to be Presented as Late-Breaker at TCT 2023

JenaValve Appoints Shlomi Nachman to Board of Directors

Contemporary Treatment of Aortic Regurgitation

egnite & JenaValve Partnership

1st Trilogy Implanted in Asia

Ken MacLeod joins Board of Directors

TAVI on the Next Level